financetom
Business
financetom
/
Business
/
Prospera Energy Swings to Q1 Operating Profit as Revenue Rises and Operating Costs Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Prospera Energy Swings to Q1 Operating Profit as Revenue Rises and Operating Costs Decline
May 31, 2024 5:05 AM

07:44 AM EDT, 05/31/2024 (MT Newswires) -- Prospera Energy ( GXRFF ) on Friday reported that it swung to an operating profit in the first-quarter as revenue rose and operating costs declined.

The company booked an operating profit of $559,907, improving from a loss of $995,840. Sales revenue jumped 168% to $4.2 million on the back of increased production and higher prices.

Prospera said that while severe cold weather weighed on the first quarter, the company was "significantly better positioned to resume production on a much quicker timeline" than last year.

For 2024, Prospera said it will continue to extend its horizontal transformational development to access untapped heavy oil reserves, with focus on developing medium-oil reserves in the third quarter.

The company will also undertake a significant vegetation, abandonment and reclamation program which could lower operating expenses and asset retirement liability.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
Nov 13, 2025
Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to an aggregate of $30.25 per share, for aggregate deal value of up to approximately $285 million Closing is expected to occur by the end of January 2026 CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) --...
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
Nov 13, 2025
Acquisition expands Day One’s portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) Emi-Le has demonstrated early anti-tumor activity in an ongoing Phase 1 study for adenoid cystic carcinoma type-1 (ACC-1), a cancer with high unmet need and a lack of therapeutic options Day One will apply existing scientific and commercial capabilities to this investigational innovative therapeutic with a clear...
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
Nov 13, 2025
New York, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited ( IGTA ) , a publicly traded special purpose acquisition company, announced today that on November 10, 2025, the Company deposited $13,242.15 into the Company’s trust account (the “Trust Account”)  in order to extend the period of time the Company has to complete a business combination for an...
Bilibili Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
Bilibili Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
Nov 13, 2025
05:31 AM EST, 11/13/2025 (MT Newswires) -- Bilibili ( BILI ) reported Q3 adjusted net profit Thursday of 1.75 Chinese renminbi ($0.25) per diluted American depositary share, up from 0.57 renminbi a year earlier. Analysts polled by FactSet expected 1.47 renminbi. Net revenue for the quarter ended Sept. 30 was 7.69 billion renminbi, up from 7.31 billion renminbi a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved